Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products.Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules.
The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period.
The Cell-based assays segment is expected to account for the largest share of the bioanalytical testing services market The increasing prevalence of chronic diseases and the rising number of clinical trials are expected to support the growth of the cell-based assays market.Cell-based assays are in vitro assays used for the quantitative and qualitative assessment of cellular mechanisms and functions using a wide range of reagents and cells.
These assays are used to study the characteristics of a cell in natural conditions.
The the oncology segment is expected to account for the largest share of the bioanalytical testing services market The oncology segment accounted for the largest share of the global bioanalytical testing services market in 2021.With the increasing burden of cancer on healthcare systems worldwide, both government and private organizations are increasingly focusing on developing novel cancer therapies.
This is expected to drive the demand for bioanalytical testing services in the clinical trials of cancer drugs. ICON (Ireland), Syneos Health (US), and PAREXEL International (US) are the leading players offering services for the clinical trials of oncology drugs.
The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the bioanalytical testing services market The pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the global bioanalytical testing services market in 2021.Pharmaceutical and biopharmaceutical companies mainly focus on developing new drugs for the treatment of various diseases.
These companies need to submit specific data related to drug development during the drug development process and subsequent filing of applications to regulatory bodies. This necessitates a wide spectrum of services in the early development phases and clinical phases to comply with regulatory requirements.
Asia Pacific market to witness the highest growth during the forecast period The APAC market is estimated to grow at the highest CAGR during the forecast period. This is majorly attributed to the rapid growth in the pharmaceutical and biopharmaceutical industries, low cost of clinical trials, and favorable government policies in several countries in this region.
A breakdown of the primary participants for the bioanalytical testing services market referred to for this report is provided below: • By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20% • By Designation: C-level–30%, Director Level–55%, and Others–15% • By Region: North America–40%, Europe–25%, Asia Pacific–20%, Latin America- 10%, Middle East & Africa-5%
The prominent players in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group (UK), Syneos Health (US), ICON (Ireland), Frontage Labs (US), PPD (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs (India), LGS Limited (UK), Sartorius AG (Germany), CD BioSciences (US), Absorption Systems LLC (US), Pace Analytical Services (US), Bioneeds India Private Limited (India) and Vipragen Biosciences (India).
Research Coverage: The report analyzes the market for various bioanalytical testing services and their adoption pattern.It aims at estimating the market size and future growth potential of the global bioanalytical testing services market and different segments such as type, application, end user, and region.
The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global bioanalytical testing services market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global bioanalytical testing services market • Market Development: Comprehensive information on the lucrative emerging regions by type, application, end user, and region • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global bioanalytical testing services market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global bioanalytical testing services market.
Our reports have been used by over 10K customers, including:
Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By End-use, By Category, By Indication, By Product Stage, By Service Provider, By Company Size, By Region, And Segment Forecasts, 2022 - 2030 Regulatory Affairs Market Growth & Trends The global regulatory affairs market...
Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Drugs In Development, 2022, provides an overview...
The global particle counters market is estimated to reach USD 825 million by 2027 from USD 511 million in 2022, at a CAGR of 10.0% from 2022 to 2027. Supportive government regulations for effective air and water pollution monitoring and control, supportive regulations and standards for cleanrooms and manufacturing, growing focus on the quality...
The global efficacy testing market is projected to reach USD 423 million by 2027 from USD 315 million in 2022, at a CAGR of 6.1% during the forecast period. The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and...
The research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility,...
The chromatography resin market is estimated to grow to USD 3.8 billion by 2027 from USD 2.6 billion in 2022, at a CAGR of 8.0%. Chromatography is one of the most used analytical techniques in the quality testing and quality control of processed food products and various beverages. According to World Health Organization, food contamination...
200 pages •
By Roots Analysis Private Ltd.
• Jun 2022
INTRODUCTION The oral solid dosage (OSD) market is the largest segment in the pharmaceutical industry, anticipated to reach over USD 900 billion by 2027. However, one of key concerns associated with this industry is that the active pharmaceutical ingredients (APIs) used in orally administered dosage forms inherently possess...
The Global Pharmaceutical Contract Manufacturing Organization (CMO) Market was valued at USD 134.12 billion in 2021, and it is expected to reach USD 204.14 billion by 2027, registering a CAGR of 6.64% from 2022 to 2027. As a result of the rising demand for generic medicines and biologics, the capital-intensive nature of the business, and the...
The global single-use bioreactors market reached a value of US$ 2.54 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 6.23 Billion by 2027, exhibiting a CAGR of 15.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...
The Global Regulatory Affairs Outsourcing Market is expected to grow at a CAGR of 12.73%. The following factors will drive the global regulatory affairs outsourcing market growth during the forecast period: • Increasing Use of Digital Platforms/Solutions in Regulatory Affairs • Changing Regulatory Landscape • Rising...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.